Zarxio
Payments companies reported to CMS as associated with Zarxio. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Zarxio, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Zarxio
These are the largest totals companies reported as associated with Zarxio. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Robert Gelfand | New York, NY | Hematology & Oncology | $52.79 |
| Regina Berkovich | West Hollywood, CA | Neurology (Psychiatry & Neurology) | $30.21 |
| Swee Jian Ngeow | Flemington, NJ | Hematology & Oncology | $30.13 |
| Tara Difabio | Flemington, NJ | Nurse Practitioner | $30.13 |
| Waqas Rehman | Flemington, NJ | Hematology & Oncology | $30.13 |
| Caroline Fitzpatrick | New York, NY | Family | $25.45 |
| Morgan Dorsey | Glastonbury, CT | Physician Assistant | $22.32 |
| Navneet Mittal | Live Oak, TX | Hematology & Oncology | $20.48 |
| Hamed Khosravi | Woodbridge, VA | Hematology & Oncology | $20.11 |
| Navid Mokhtari Amirmajdi | Towson, MD | Hematology & Oncology | $20.11 |
Prescribed Zarxio?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.